Policy | December 29, 2025
Govt cancels registration of popular cosmetic product over misleading claims
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
The cancellation underscores the regulator’s strict stance against misleading cosmetic claims
U.S. and Canada transaction supports continued access to RADICAVA for people living with ALS
Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
Biocon will be responsible for supplying Semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in 3 countries across Africa, Middle East and Central Asia
Emcure becomes the first Indian company to exclusively distribute and commercialise Poviztra, a second brand of Novo Nordisk’s Semaglutide injection for weight management
USFDA determines Sun Pharma's Baska facility inspection classification as OAI
This marks the first partnership between Pfizer and Cipla in India
The new facility is expected to generate 500-600 new jobs in the region
The state-of-the-art facility is expected to be commissioned over the next three years
,_Thyrocare_256_384.jpg)
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
Subscribe To Our Newsletter & Stay Updated
